Showing results (171-180 of 292) with videos related to

Sort By:
Pageof 30
CMAJ Open|April 7, 2015
Patterns of use for brand-name versus generic oral bisphosphonate drugs in Ontario over a 13-year period: a descriptive studyLisa-Ann Fraser, Jordan M Albaum, Mina Tadrous, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 24, 2011
Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, CanadaA M Burden, J M Paterson, D H Solomon, et al.
Peptides|February 16, 2010
Stimulation of N-cadherin-dependent neurite outgrowth by small molecule peptide mimetic agonists of the N-cadherin HAV motifSusan M Burden-Gulley, Theresa J Gates, Sonya E L Craig, et al.
Nature Structural Biology|February 15, 2001
The 2.0 A structure of human ferrochelatase, the terminal enzyme of heme biosynthesisC K Wu, H A Dailey, J P Rose, et al.
The Journal of Clinical Endocrinology and Metabolism|April 10, 2025
Direct healthcare cost of fractures in patients with type 1 diabetes: a population-based cohort study in DenmarkAnnika Vestergaard Kvist, Morten Frost, Andrea M Burden, et al.
Journal of Pharmaceutical Policy and Practice|October 1, 2020
Community pharmacist-administered seasonal influenza vaccination: a national customer surveyDominik Stämpfli, Adrian Martinez-De la Torre, Sophie Du Pasquier, et al.
Biochimie|June 25, 2008
Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1A K Marr, H Jenssen, M Roshan Moniri, et al.
Asian Journal of Psychiatry|April 8, 2019
Recalled pre-school activities among adults with gender dysphoria who seek gender confirming treatment-An Iranian studyGhasem M Roshan, Ali Talaei, Mostafa Sadr, et al.
The Journal of Clinical Pediatric Dentistry|January 30, 2015
Evaluation of probiotic milk on salivary mutans streptococci count: an in vivo microbiological studyM Yadav, P Poornima, N M Roshan, et al.
Biochemistry|November 26, 1999
DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancementJ A Byl, J M Fortune, D A Burden, et al.
Pageof 30